Quick Answer
Semnur Pharmaceuticals, Inc. reported Stockholders Equity of -$20.75 million for the year ending 2025.
- Semnur Pharmaceuticals, Inc. showed an increase of +51.5% in Stockholders Equity from 2024 to 2025.
- This data is from Semnur Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2021: $0.00 | Q1 2022: $13.7 thousand | Q2 2022: -$1.67 million | Q3 2022: -$1.86 million | Q1 2023: -$5.19 million | Q2 2023: -$6.59 million | Q3 2023: -$7.93 million | Q1 2024: -$39.60 million | Q2 2024: -$40.71 million | Q3 2024: -$42.01 million | Q1 2025: -$43.45 million | Q2 2025: -$44.45 million | Q3 2025: -$14.59 million.
- Historical annual values: Fiscal year 2025: -$20.75 million | Fiscal year 2024: -$42.78 million | Fiscal year 2023: -$38.09 million | Fiscal year 2022: -$3.27 million | Fiscal year 2021: $0.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: